AMOXICILLIN\CLARITHROMYCIN\LANSOPRAZOLE: 261 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
261
Total FAERS Reports
6 (2.3%)
Deaths Reported
51
Hospitalizations
261
As Primary/Secondary Suspect
8
Life-Threatening
4
Disabilities
First Report: 200312 · Latest Report: 20220608
What Are the Most Common AMOXICILLIN\CLARITHROMYCIN\LANSOPRAZOLE Side Effects?
#1 Most Reported
Chronic kidney disease
114 reports (43.7%)
#2 Most Reported
Acute kidney injury
62 reports (23.8%)
#3 Most Reported
End stage renal disease
41 reports (15.7%)
All AMOXICILLIN\CLARITHROMYCIN\LANSOPRAZOLE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Chronic kidney disease | 114 | 43.7% | 6 | 6 |
| Acute kidney injury | 62 | 23.8% | 5 | 6 |
| End stage renal disease | 41 | 15.7% | 6 | 5 |
| Renal failure | 36 | 13.8% | 1 | 5 |
| Renal injury | 15 | 5.8% | 0 | 1 |
| Diarrhoea | 14 | 5.4% | 0 | 3 |
| Dysgeusia | 12 | 4.6% | 0 | 1 |
| Nausea | 11 | 4.2% | 0 | 5 |
| Vomiting | 10 | 3.8% | 0 | 4 |
| Dizziness | 9 | 3.5% | 0 | 3 |
| Insomnia | 9 | 3.5% | 0 | 3 |
| Drug interaction | 8 | 3.1% | 0 | 2 |
| Malaise | 8 | 3.1% | 0 | 3 |
| Tubulointerstitial nephritis | 7 | 2.7% | 1 | 1 |
| Chest pain | 6 | 2.3% | 0 | 4 |
| Decreased appetite | 6 | 2.3% | 0 | 2 |
| Drug eruption | 6 | 2.3% | 0 | 4 |
| Rash | 6 | 2.3% | 0 | 2 |
| Anxiety | 5 | 1.9% | 0 | 1 |
| Drug hypersensitivity | 5 | 1.9% | 0 | 2 |
Who Reports AMOXICILLIN\CLARITHROMYCIN\LANSOPRAZOLE Side Effects? Age & Gender Data
Gender: 68.3% female, 31.7% male. Average age: 61.3 years. Most reports from: US. View detailed demographics →
Is AMOXICILLIN\CLARITHROMYCIN\LANSOPRAZOLE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2003 | 1 | 0 | 0 |
| 2004 | 3 | 0 | 2 |
| 2005 | 6 | 0 | 2 |
| 2006 | 5 | 0 | 2 |
| 2007 | 1 | 0 | 1 |
| 2008 | 17 | 3 | 2 |
| 2009 | 11 | 0 | 4 |
| 2010 | 7 | 2 | 0 |
| 2011 | 5 | 0 | 0 |
| 2012 | 10 | 0 | 1 |
| 2013 | 10 | 0 | 4 |
| 2014 | 19 | 1 | 9 |
| 2015 | 17 | 0 | 5 |
| 2016 | 13 | 0 | 3 |
| 2017 | 5 | 0 | 3 |
| 2018 | 10 | 0 | 4 |
| 2020 | 1 | 0 | 0 |
| 2021 | 1 | 0 | 0 |
| 2022 | 1 | 0 | 1 |
What Is AMOXICILLIN\CLARITHROMYCIN\LANSOPRAZOLE Used For?
| Indication | Reports |
|---|---|
| Helicobacter infection | 72 |
| Product used for unknown indication | 72 |
| Gastrooesophageal reflux disease | 59 |
| Dyspepsia | 16 |
| Helicobacter gastritis | 6 |
AMOXICILLIN\CLARITHROMYCIN\LANSOPRAZOLE vs Alternatives: Which Is Safer?
AMOXICILLIN\CLARITHROMYCIN\LANSOPRAZOLE vs AMOXICILLIN\CLAVULANATE
AMOXICILLIN\CLARITHROMYCIN\LANSOPRAZOLE vs AMOXICILLIN\CLAVULANIC ACID
AMOXICILLIN\CLARITHROMYCIN\LANSOPRAZOLE vs AMOXICILLIN\OMEPRAZOLE\RIFABUTIN
AMOXICILLIN\CLARITHROMYCIN\LANSOPRAZOLE vs AMPHETAMINE
AMOXICILLIN\CLARITHROMYCIN\LANSOPRAZOLE vs AMPHETAMINE ASPARTATE\AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE
AMOXICILLIN\CLARITHROMYCIN\LANSOPRAZOLE vs AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE
AMOXICILLIN\CLARITHROMYCIN\LANSOPRAZOLE vs AMPHETAMINE\DEXTROAMPHETAMINE
AMOXICILLIN\CLARITHROMYCIN\LANSOPRAZOLE vs AMPHOTERICIN B
AMOXICILLIN\CLARITHROMYCIN\LANSOPRAZOLE vs AMPHOTERICIN B\DIMYRISTOYLPHOSPHATIDYLCHOLINE, DL-\DIMYRISTOYLPHOSPHATIDYLGLYCEROL, DL-
AMOXICILLIN\CLARITHROMYCIN\LANSOPRAZOLE vs AMPICILLIN
Official FDA Label for AMOXICILLIN\CLARITHROMYCIN\LANSOPRAZOLE
Official prescribing information from the FDA-approved drug label.